Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Orthofix Medical (OFIX) Other financing activities (2016 - 2026)

Orthofix Medical has reported Other financing activities over the past 16 years, most recently at $24000.0 for Q1 2026.

For the quarter ending Q1 2026, Other financing activities fell 95.31% year-over-year to $24000.0, compared with a TTM value of $43000.0 through Mar 2026, down 98.34%, and an annual FY2025 reading of $531000.0, down 85.37% over the prior year.
Other financing activities came in at $24000.0 for Q1 2026, up from $19000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $1.7 million in Q4 2023 to a low of -$23000.0 in Q1 2022.
Median Other financing activities over the past 5 years was $225000.0 (2024), compared with a mean of $488769.2.
The sharpest move saw Other financing activities surged 1921.74% in 2023, then crashed 97.75% in 2025.
Over 5 years, Other financing activities stood at $160000.0 in 2022, then surged by 936.25% to $1.7 million in 2023, then tumbled by 38.9% to $1.0 million in 2024, then crashed by 98.12% to $19000.0 in 2025, then rose by 26.32% to $24000.0 in 2026.
Per Business Quant, the three most recent readings for OFIX's Other financing activities are $24000.0 (Q1 2026), $19000.0 (Q2 2025), and $512000.0 (Q1 2025).